“The DVT in 2022 almost killed me. The post-thrombotic syndrome it left behind has been slowly draining my quality of life ever since. My hematologist told me there was no cure — just management. Leech therapy did not cure me either, but it gave me back enough function to live something approaching a normal life.”
Sarah W., a 52-year-old hospital administrator from Minneapolis, Minnesota, describes her experience with adjunctive leech therapy for refractory post-thrombotic syndrome (PTS), two years after a provoked deep vein thrombosis.
Background: DVT and Its Aftermath
In March 2022, Sarah developed an extensive proximal DVT (iliofemoral) following a long-haul flight combined with oral contraceptive use. She was hospitalized, anticoagulated (enoxaparin → apixaban), and the DVT resolved partially on 6-month anticoagulation. However, duplex ultrasound at 12 months confirmed chronic venous obstruction and valvular incompetence — the structural basis for post-thrombotic syndrome. She was left with daily pain (VAS 6-7/10), leg heaviness, venous claudication at 200m walking, and recurrent skin changes.
“I walked out of the hospital thinking I had survived the worst of it. The DVT was gone — mostly. What I did not understand was that the damage it left in my vein wall would be with me for years. The post-thrombotic syndrome was in some ways harder than the acute event.”
Standard Post-Thrombotic Management
Sarah's hematologist and vascular team implemented the evidence-based PTS management protocol: class III compression stockings (40-50 mmHg), elevation, graduated walking program, physiotherapy, venotonics (diosmin). After 18 months, her Villalta PTS score improved from 16 (severe) to 12 (moderate) — improvement but persistent significant burden. She declined catheter-directed thrombolysis given the late presentation.
“I followed every recommendation. I slept with my leg elevated. I wore those heavy stockings every day. I did the physio. My scores improved on paper, but I still could not walk more than two blocks without stopping.”
Leech Therapy as Adjunctive Treatment
Sarah consulted an ASH practitioner familiar with venous disease at month 20 post-DVT. The biological rationale for PTS: destabilase (leech fibrinolytic enzyme) targeting residual fibrin in the recanalized vein; eglin-class anti-inflammatories reducing vein wall inflammation; vasodilators improving microcirculation in the post-thrombotic leg. Protocol: 6 sessions over 3 months, applied to medial calf/thigh along the course of the affected vein, with continued standard compression therapy.
“After the fourth session, I walked 6 blocks before my claudication stopped me. That was three times my previous distance. I stood in the middle of the sidewalk and cried. I had forgotten what it felt like to just walk somewhere.”
Functional Improvement
Villalta PTS score: 12 → 7 (mild PTS) after 6 sessions. Pain: VAS 6-7/10 → 3/10 (57% reduction). Walking distance: 200m → 600m before claudication. Skin changes (lipodermatosclerosis) stable, no new ulceration. Subjective symptom burden significantly reduced.
“PTS is permanent. My veins are damaged and that will not change. But leech therapy has made living with it so much more manageable. I am at work full time, I walk my dog every morning, and I sleep through the night most nights. That is a different life than I had 2 years ago.”
Key Outcomes
Medical Perspective
Treating Physician
Dr. Maria Santos, MD
Hematology and Vascular Medicine
“Post-thrombotic syndrome is a condition with high unmet therapeutic need — current evidence-based options provide modest symptom reduction but no structural resolution. The biological rationale for leech therapy in PTS is compelling: destabilase's fibrinolytic activity, complement inhibition reducing vein wall inflammation, and sustained vasodilation improving microvascular flow. Sarah's 57% pain reduction and tripling of walking distance exceed what we typically achieve with compression alone. A controlled trial in PTS would be the appropriate next step.”
Medical Disclaimer
Individual results vary. These stories represent personal experiences and are not guarantees of outcome. Leech therapy requires proper medical supervision. Consult a qualified healthcare provider before starting any treatment.